These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38645782)

  • 1. Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Tzu Chi Med J; 2024; 36(2):110-119. PubMed ID: 38645782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Hsu YH; Kuo HC
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
    Jiang YH; Jhang JF; Kuo HC
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome.
    Jhang JF; Jiang YH; Kuo HC
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.
    Jiang YH; Jhang JF; Kuo HC
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.
    Yu WR; Chang WC; Kuo HC
    Int Urol Nephrol; 2022 Sep; 54(9):2157-2165. PubMed ID: 35804206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients.
    Jiang YH; Jhang JF; Wu YH; Kuo HC
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study.
    Chow PM; Kuo HC
    Int Urol Nephrol; 2022 Oct; 54(10):2497-2502. PubMed ID: 35857158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
    Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Urine Biomarkers to Differentiate Bladder Dysfunctions in Women with Sensory Bladder Disorders.
    Chen YC; Jiang YH; Jhang JF; Kuo HC
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction.
    Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL
    medRxiv; 2023 Apr; ():. PubMed ID: 37131628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction.
    Jiang YH; Chen SF; Kuo HC
    Tzu Chi Med J; 2020; 32(2):121-130. PubMed ID: 32269943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical symptoms are not reliable in the diagnosis of lower urinary tract dysfunction in women.
    Kuo HC
    J Formos Med Assoc; 2012 Jul; 111(7):386-91. PubMed ID: 22817816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
    Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
    BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome.
    Jhang JF; Yu WR; Huang WT; Kuo HC
    World J Urol; 2024 Mar; 42(1):173. PubMed ID: 38507059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges in the diagnosis of detrusor underactivity in clinical practice: A mini-review.
    Ahmed A; Farhan B; Vernez S; Ghoniem GM
    Arab J Urol; 2016 Sep; 14(3):223-7. PubMed ID: 27547465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Biomarkers Utilized to Define and Manage Overactive Bladder Syndrome.
    Kuo HC
    Low Urin Tract Symptoms; 2012 Mar; 4 Suppl 1():32-41. PubMed ID: 26676698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.